IFOM Alberto Bardelli Lab

Alberto Bardelli Lab

AlbertoBardelli

Alberto Bardelli

Alberto Bardelli, a molecular geneticist and expert in the field of personalized therapies, has been the Scientific Director of IFOM since 2022. He also leads the Genomics of Cancer and Targeted Therapies Unit and is Full Professor at the University of Turin. read more

Contact the researcher

Genomics of Cancer and Targeted Therapies

In the past 15 years it has become clear that cancer has a genetic basis and that mutations affecting the coding sequences of specific genes are the hallmark of this disease. This knowledge has already had a dramatic impact in the clinical arena. read more

Laboratory location: Turin, Italy

Selected publications

Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance.
Vitiello PP, Rousseau B, Chilá R, Battuello P, Amodio V, Battaglieri V, Grasso G, Scardellato S, Anselmo A, Clemente F, Rospo G, Lamba S, Bartolini A, Pisati F, Tripodo C, Congiusta N, Russo M, Crisafulli G, Di Nicolantonio F, Germano G, Diaz LJr, Bardelli A.
Cancer Cell. 2025 Jun 10:S1535-6108(25)00223-5.

Tumor ‘Age’ in Early-Onset Colorectal Cancer.
Mauri G, Patelli G, Crisafulli G, Siena S, Bardelli A.
Cell. 2025 Feb 6;188(3):589-593.

Cancer drug-tolerant persister cells: from biological questions to clinical opportunities.
Russo M, Misale S, Wei G, Siravegna G, Crisafulli G, Lazzari L, Corti G, Rospo G, Novara L, Mussolin B, Bartolini A, Cam N, Patel R, Yan S, Shoemaker R, Wild R, Di Nicolantonio F, Sartore-Bianchi A, Li G, Siena S, Bardelli A.
Nat Rev Cancer. 2024 Oct;24(10):694-717.

Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells.
Sogari A, Rovera E, Grasso G, Mariella E, Reilly NM, Lamba S, Mauri G, Durinikova E, Vitiello PP, Lorenzato A, Avolio M, Piumatti E, Bonoldi E, Aquilano MC, Arena S, Sartore-Bianchi A, Siena S, Trusolino L, Donalisio M, Russo M, Di Nicolantonio F, Lembo D, Bardelli A.
Cell Rep Med. 2024 Feb 20;5(2):101376.

Precision oncology for KRASG12C-mutant colorectal cancer.
Di Nicolantonio F, Bardelli A.
Nat Rev Clin Oncol. 2023 Jun;20(6):355-356.

Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance.
Amodio V, Lamba S, Chilà R, Cattaneo CM, Mussolin B, Corti G, Rospo G, Berrino E, Tripodo C, Pisati F, Bartolini A, Aquilano MC, Marsoni S, Mauri G, Marchiò C, Abrignani S, Di Nicolantonio F, Germano G, Bardelli A.
Cancer Cell. 2023 Jan 9;41(1):196-209.

Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.
Sartore-Bianchi A, Pietrantonio F, Lonardi S, Mussolin B, Rua F, Crisafulli G, Bartolini A, Fenocchio E, Amatu A, Manca P, Bergamo F, Tosi F, Mauri G, Ambrosini M, Daniel F, Torri V, Vanzulli A, Regge D, Cappello G, Marchiò C, Berrino E, Sapino A, Marsoni S, Siena S, Bardelli A.
Nat Med. 2022 Aug;28(8):1612-1618.

Group members - IFOM

Assistant Professor
Giovanni Germano, Project Leader of My First AIrc Grant 2020 - ID 20604
Staff Scientist
Rosaria Chilà
Bioinformatician
Giovanni Crisafulli
Post Doc
Vito Amodio
Flaminia Pedretti
Bianca Pellegrino
Pietro Paolo Vitiello
Physician Scientist
Vincenzo Guastafierro
Giorgio Patelli
PhD student
Vittorio Battaglieri
Veronica Gurrisi
Federico Lazzarini
Guest Researcher
Simona Destefanis
Gaia Grasso
Elisa Mariella
Gianluca Mauri
Veera Katariina Ojala
Mariangela Russo
Nadia Saoudi Gonzalez
Lab Technician
Alessia Anastasia
Temporary Fellow
Emma Tassanelli
Undergraduate Student
Luca Giordano


(update: Jan 2026)

Group members - University of Turin

Assistant Professor
Mariangela Russo
Postoctoral Fellow
Federica Gentile
Gaia Grasso
Elisa Mariella
Alberto Sogari
PhD student
Martina Miotto
Luca Russolillo
Alessia Subrizio
Research Technicians
Simona Lamba
Adminstrative Staff
Simona Destefanis